Abstract
Polymeric palladium complexes [(C5H12NO)(PdCl3)]n (I) and [(C10H16NO)2(Pd2Cl6)] (II) were synthesized for the first time and studied by X-ray diffraction. Complexes I and II were found to have moderate toxicity (3rd class of toxicity) and high antitumor and radioprotective activities. Treatment of Lewis lung carcinoma (LLC) with I and II induced statistically significant antitumor and antimetastatic effects exceeding those of cisplatin: the use of I and II retarded the growth of LLC by 60.0%, while cisplatin retarded it by 48.0%. The decrease in the LLC metastasis was 75% upon the action of I, 91.0% in the case of II, and 69.0% for cisplatin. It was shown that II has a clear-cut radioprotective action. On single exposure of mice to a dose of 8.2 Gy, their survival rate was 58.0% versus 4.5% for the control. Fractional exposure to increasing doses (2.5, 3, and 3.5 Gy) resulted in 75.0% survival rate versus 33.0% for the control.
Similar content being viewed by others
REFERENCES
Lippert, B., Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, Weinheim: Wiley-VCH, 1995.
Fulford, A., Plat. Met. Rev., 1966, vol. 40, no. 4, p. 161.
Giachetti, S., Perpoint, B., Zidani, R., et al., J. Clin. Oncol., 2000, vol. 18, p. 136.
Weiss, R.V. and Poster, D.S., Cancer Treat. Rev., 1982, vol. 9, p. 37.
Groth, S., Nielsen, H., Sorensen, J., et al., Cancer Chemother. Pharmacol., 1986, vol. 17, p. 191.
Petrov, V.I., Fisenko, V.P., Arzamatsev, E.V., et al., Guide on Experimental (Pre-Clinical) Study of New Substances for Pharmacology, Remedium, 2000, p. 398.
Brienza, S., Vignoud, J., Itznaki, M., et al., Proc. Am. Soc. Clin. Oncol., 1995, vol. 14, p. 209.
Dress, M., Dengler, W.M., Hendrics, H.R., et al., Eur. J. Cancer. A, 1995, vol. 31, p. 356.
Levi, F., Perpoint, B., Garuit, C., et al., Eur. J. Cancer, Part A, 1993, vol. 29, p. 1608.
Efimenko, I.A., Koord. Khim., 1998, vol. 24, no. 4, p. 282.
Zakharova (Efimenko), I.A., Issledovaniya po neorganicheskoi khimii i khimicheskoi tekhnologii (Studies in Inorganic Chemistry and Chemical Engineering), Moscow: Nauka, 1988, p. 171.
Efimenko, I.A. and Shishilov, O.N., Russ. J. Inorg. Chem., 2012, vol. 57, no. 14, p. 1695. https://doi.org/10.1134/S0036023612140021
Efimenko, I.A., Churakov, A.V., Ivanova, N.A., et al., Russ. J. Inorg. Chem., 2017, vol. 62, p. 1469. https://doi.org/10.1134/S0036023617110043
Efimenko, I.A., Shishilov, O.N., Ivanova, N.A., et al., Precious Met., 2012, vol. 33, p. 240.
Zakharova, I.A., Zhavoronkov, N.M., Kurbanov, T.Kh., et al., USSR Inventor’s Certificate no. 1412229, 1988.
Efimenko, I.A., Kurbakova, A.P., Grap, S.R. et al., RF Patent 2022968, Byull. Izobret., 1994, no. 21.
Efimenko, I.A., Lokshin, B.V., and Ivanova, N.A., RF Patent 2089186, Byull. Izobret., 1997, no. 25.
Efimenko, I.A. and Ivanova, N.A., Eurasian Patent no. 010431, Byull. Izobret., 2008, no. 4.
Kuznetsov, N.T., Efimenko, I.A., Ivanova, N.A. et al., RF Patent 2613305, Byull. Izobret., 2017, no. 8.
Tikhomirov, A.G., Ivanova, N.A., Erofeeva, O.S., et al., Russ. J. Coord. Chem., 2003, vol. 29, no. 7, p. 489. https://doi.org/10.1023/A:1024731014000
Akat’eva, M.E., Erofeeva, O.S., Dobrynina, N.A., et al., Russ. J. Coord. Chem., 2004, vol. 30, no. 8, p. 584. https://doi.org/10.1023/B:RUCO.0000037439.30356.e0
Gorbacheva, L.B., Tikhomirov, A.G., and Dederer, L.Yu., Khim.-Farm. Zh., 2008, vol. 42, no. 2, p. 3.
Grekhova, A.K., Gorbacheva, L.B., and Ivanova, N.A., Biomed. Khim., 2013, vol. 59, no. 1, p. 107.
Shishilov, O.N., Stromnova, T.A., Churakov, A.V., et al., Russ. J. Inorg. Chem., 2006, vol. 51, p. 574. https://doi.org/10.1134/S0036023606040127
Qi-Pin Qin, Bi-Qun Zou, Ming-Xiong Tan, et al., Inorg. Chem. Commun., 2018, vol. 96, p. 106.
Efimenko, I.A., Churakov, A.V., Erofeeva, O.S., et al., Russ. J. Coord. Chem., 2019, vol. 45, no. 9, p. 615. https://doi.org/10.1134/S1070328419090033
Sheldrick, G.M., SADABS. Program for Scaling and Correction of Area Detector Data, Göttingen: Univ. of Göttingen, 1997.
Sheldrick, G.M., Acta Crystallogr., Sect. A: Found. Crystallogr., 2008, vol. 64, no. 1, p. 112.
Kawano, K., Hattori, Y., Iwakura, H., et al., Exp. Ther. Med., 2012, vol. 4, no. 1, p. 61.
Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv (Guidelines for Preclinical Studies of Medicinal Agents), Part 1. Moscow: GrifiK, 2012.
Groom, C.R. and Allen, F.H., Angew. Chem., Int. Ed. Engl., 2014, vol. 53, p. 662.
Raper, E.S., Kubiak, M., and Glowiak, T., Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 1997, vol. 53, p. 1201.
Vranec, P., Potocnak, I., and Repovsky, P., Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 2012, vol. 68, p. M370.
Berezovskaya, I.V. Toksikologicheskii vestnik, 2010, no. 5, p. 1041.
Radiatsionnaya meditsina (Radiation Medicine), Il’in, L.A., Ed., Moscow, 2004, vol. 1.
Barchukov, V.G., Efimenko, I.A., Erofeeva, O.S., et al., RF Patent, 2699809, Byull. Izobret., 2019, no. 26.
ACKNOWLEDGMENTS
The X-ray diffraction study of compound I was performed using equipment of the Center for Collective Use, Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, within the state assignment. The X-ray diffraction data for II were collected at the Department of Chemistry, Durham University (UK).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflicts of int-erest.
Additional information
Translated by Z. Svitanko
Rights and permissions
About this article
Cite this article
Efimenko, I.A., Filimonova, M.V., Churakov, A.V. et al. First Polynuclear Palladium Compounds [(C5H12NO)(PdCl3)]n and [(C10H16NO)2(Pd2Cl6)] with High Antitumor and Radioprotective Activity. Russ J Coord Chem 46, 339–349 (2020). https://doi.org/10.1134/S1070328420040028
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070328420040028